Inhibition of Cysteine Proteinases Delays Pancreatic Cancer Growth
Author Information
Author(s): Van Noorden C J F, Jonges T G N, Meade-Tollin L C, Smith R E, Koehler A
Primary Institution: Academic Medical Center, University of Amsterdam
Hypothesis
Does the oral treatment with a selective inhibitor of cysteine proteinases affect the growth of human pancreatic cancer explants?
Conclusion
The study found that cysteine proteinases play a temporary role in the early development of moderately differentiated pancreatic tumors, which can be inhibited by a specific treatment.
Supporting Evidence
- The inhibitor significantly delayed the onset of growth in moderately differentiated tumors.
- Poorly differentiated tumors were not affected by the treatment.
- The treatment increased stroma and reduced cancer cell volume in treated tumors.
Takeaway
This study shows that a special treatment can slow down the growth of certain types of pancreatic cancer in mice.
Methodology
An animal model was used where human pancreatic tumors were implanted in nude mice, which were then treated with a cysteine proteinase inhibitor.
Limitations
The study only tested the inhibitor on moderately differentiated tumors and did not affect poorly differentiated tumors.
Participant Demographics
Nude mice were used as the model organism.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website